These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9745634)

  • 1. Current pharmacotherapies for Alzheimer's disease.
    Knopman DS
    Geriatrics; 1998 Sep; 53 Suppl 1():S31-4. PubMed ID: 9745634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacologic approaches to cognitive deficits in Alzheimer's disease.
    Peskind ER
    J Clin Psychiatry; 1998; 59 Suppl 9():22-7. PubMed ID: 9720483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease: clinical treatment options.
    Reichman WE
    Am J Manag Care; 2000 Dec; 6(22 Suppl):S1125-32; discussion S1133-8. PubMed ID: 11142177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex influences on cholinesterase inhibitor treatment in elderly individuals with Alzheimer's disease.
    Haywood WM; Mukaetova-Ladinska EB
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):273-86. PubMed ID: 17062329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease: seeking new ways to preserve brain function. Interview by Alice V. Luddington.
    Davis KL
    Geriatrics; 1999 Feb; 54(2):42-7; quiz 48. PubMed ID: 10024872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options in Alzheimer's disease: maximizing benefit, managing expectations.
    Farlow MR; Miller ML; Pejovic V
    Dement Geriatr Cogn Disord; 2008; 25(5):408-22. PubMed ID: 18391487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice guidelines for the diagnosis and treatment of Alzheimer's disease in a managed care setting: Part II--Pharmacologic therapy. Alzheimer's Disease (AD) Managed Care Advisory Council.
    Fillit H; Cummings J
    Manag Care Interface; 2000 Jan; 13(1):51-6. PubMed ID: 10747691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination drug therapy for Alzheimer's disease: what is evidence-based, and what is not?
    Xiong G; Doraiswamy PM
    Geriatrics; 2005 Jun; 60(6):22-6. PubMed ID: 15948662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Searching for drugs that combat Alzheimer's.
    Marx J
    Science; 1996 Jul; 273(5271):50-3. PubMed ID: 8658194
    [No Abstract]   [Full Text] [Related]  

  • 10. Alternative drug therapies for dementia.
    Howland RH
    J Psychosoc Nurs Ment Health Serv; 2011 May; 49(5):17-20. PubMed ID: 21553703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rivastigmine and donepezil treatment in moderate to moderately-severe Alzheimer's disease over a 2-year period.
    Bullock R; Touchon J; Bergman H; Gambina G; He Y; Rapatz G; Nagel J; Lane R
    Curr Med Res Opin; 2005 Aug; 21(8):1317-27. PubMed ID: 16083542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New drugs for Alzheimer's disease.
    Delagarza VW
    Am Fam Physician; 1998 Oct; 58(5):1175-82. PubMed ID: 9787282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of Alzheimer's disease].
    López OL; Becker JT
    Rev Neurol; 2002 Nov 1-15; 35(9):850-9. PubMed ID: 12436384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease therapy - an update.
    Nikolov R
    Drug News Perspect; 1998 May; 11(4):248-55. PubMed ID: 15616667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current approaches in the treatment of Alzheimer's disease.
    Shah RS; Lee HG; Xiongwei Z; Perry G; Smith MA; Castellani RJ
    Biomed Pharmacother; 2008; 62(4):199-207. PubMed ID: 18407457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Future therapeutic approaches to Alzheimer's disease.
    Davis KL
    J Clin Psychiatry; 1998; 59 Suppl 11():14-6. PubMed ID: 9731545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options in Alzheimer's disease.
    Moreira PI; Zhu X; Nunomura A; Smith MA; Perry G
    Expert Rev Neurother; 2006 Jun; 6(6):897-910. PubMed ID: 16784412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis.
    Sugimoto H
    Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease.
    Wynn ZJ; Cummings JL
    Dement Geriatr Cogn Disord; 2004; 17(1-2):100-8. PubMed ID: 14564129
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.